FIELD: pharmaceutics.
SUBSTANCE: what is presented is an agent for therapeutic treatment and prevention of fungal diseases of skin and appendages of skin, and extensive and systemic fungal infections of human and animal skin, characterised by the fact that it represents benzyl benzoate and a pharmaceutical composition containing at least 0.1 wt % of this agent High activity of benzyl benzoate on most species of fungal agents and high therapeutic efficacy have been shown.
EFFECT: invention can find application in pharmaceutical industry, medicine, veterinary science, cosmetology and personal hygiene products.
22 cl, 8 ex
Authors
Dates
2016-01-27—Published
2008-02-05—Filed